242 related articles for article (PubMed ID: 12233217)
1. [Clinical case of the month. Treatment of obstructive hypertrophic cardiomyopathy by percutaneous septal ablation].
Hoffer E; Boland J
Rev Med Liege; 2002 Jul; 57(7):433-7. PubMed ID: 12233217
[TBL] [Abstract][Full Text] [Related]
2. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
3. "Moving left ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Akita K; Maekawa Y; Tsuruta H; Okuda S; Yanagisawa R; Kageyama T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
Int J Cardiol; 2016 Jan; 202():194-5. PubMed ID: 26397409
[No Abstract] [Full Text] [Related]
4. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
Seggewiss H; Faber L
Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
[TBL] [Abstract][Full Text] [Related]
6. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
Veselka J
Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
[TBL] [Abstract][Full Text] [Related]
7. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
Noble S; Sigwart U
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
[TBL] [Abstract][Full Text] [Related]
10. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
11. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
Lawrenz T; Kuhn H
Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
[TBL] [Abstract][Full Text] [Related]
12. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.
Aksu T; Guler T; Yalin K; Golcuk SE; Ozcan K
Am J Med Sci; 2016 Nov; 352(5):466-471. PubMed ID: 27865293
[TBL] [Abstract][Full Text] [Related]
13. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Kimmelstiel CD; Maron BJ
Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
[No Abstract] [Full Text] [Related]
14. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard.
Brown ML; Schaff HV
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous transluminal septal myocardial ablation performed via the right coronary artery rather than the left anterior descending artery for the treatment of hypertrophic obstructive cardiomyopathy.
Takagi K; Mukawa H; Morishima I; Uesugi M; Okumura Y; Tsuboi H; Sone T
Int J Cardiol; 2013 Jan; 162(3):e51-2. PubMed ID: 22981456
[No Abstract] [Full Text] [Related]
16. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
[TBL] [Abstract][Full Text] [Related]
17. Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
Chen SL; Ye F; Xu ZL; Lin S; Duan BX; Dai ZL; Shan SJ; Zhang JJ
Chin Med J (Engl); 2006 Jul; 119(13):1121-4. PubMed ID: 16834933
[No Abstract] [Full Text] [Related]
18. Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report.
Tengiz I; Ercan E; Alioglu E; Turk UO
BMC Cardiovasc Disord; 2006 Apr; 6():15. PubMed ID: 16606458
[TBL] [Abstract][Full Text] [Related]
19. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
[TBL] [Abstract][Full Text] [Related]
20. A repeat alcohol septal ablation procedure for hypertrophic obstructive cardiomyopathy where the first septal branch arose from the intermediate (ramus) artery.
Doran GC; Burns CM; Murdoch DJ; Incani A; Walters DL
Heart Lung Circ; 2013 Dec; 22(12):1026-9. PubMed ID: 23706939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
